Evaluation of anticonvulsant activity of ACE inhibitors (imidapril and quinapril) in experimentally induced animal models of epilepsy

Pushpa VH, Poornima R., Kalabharathi HL, Satish AM


Background: Epilepsy is a chronic neurological disorder characterized by an enduring predisposition to generate seizures, may be associated with emotional and cognitive dysfunction. Objective of this study was to evaluate and compare the anticonvulsant activity of different doses of imidapril and quinapril in animal models of epilepsy.

Methods: Swiss albino mice weighing around 25-30g of either sex were divided into 6 groups: control (R.O-10 ml/kg), standard-sodium valproate (40 mg/kg), Q1-quinapril (1.5 mg/kg), Q2-quinapril (10.4 mg/kg), I1-imidapril (0.65mg/kg) and I2-imidapril (2.6 mg/kg). 1 hour after administration of control, test and standard drugs (orally) test was conducted. Convulsions were induced by administering PTZ (70 mg/kg-i.p.) in PTZ model. Seizure latency was the parameter recorded. In MES model, maximal seizures were evoked by supra maximal electroshock stimulation of 50 mA, 50 HZ for 0.2 seconds by using conventional electro convulsion meter. Suppression of tonic hind limb extension was taken as measure of efficacy.

Results: The results were analysed by one-way-ANOVA followed by Bonferroni’s multiple comparison test. In MES test, dose dependently quinapril and imidapril significantly reduced the duration of tonic hind limb extension in comparison to control (p<0.05) percentage inhibition of seizures by I2 is 58.1%, I1-38.6%, Q2-19.7% and Q1-12.2% with maximum inhibition of seizure produced by I2 in comparison to control in MES test. In PTZ test, dose dependently quinapril and imidapril produced significant increase in seizure latency (p<0.05). Percentage inhibition of seizures by I2-65.8%, I1-59.3%, Q2-50.9% and Q1-33.5% in comparison to control.

Conclusions: Quinapril and imidapril in a dose dependent manner showed increase in antiepileptic activity, imidapril has better antiepileptic activity when compared to quinapril.


Antiepileptic activity, ACE inhibitor, MES model, PTZ model, Quinapril, Imidapril

Full Text:



Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult epilepsy. Lancet. 2006;367:1087-100.

Perucca E, French J, Bialer M. Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol. 2007;6:793-804.

Pandy V, Subash H, Jose N. Depression like effects of telmisartan in mice forced swim test: involvement of brain monoaminergic system. Journal of Pharmacology and Toxicology. 2012;7(2):87-95.

Ramírez-Sánchez M, Prieto I, Wangensteen R, Banegas I, Segarra AB, Villarejo AB, et al. The renin-angiotensin system: new insight into old therapies. Curr Med Chem. 2013;20(10):1313-22.

Hosseini M, Alaei H, Sharifi MR, Shafeia MS. The effects of angiotensin II and captopril on expression of morphine withdrawal signs in rats. IJPR. 2007;6(3):185-91.

Xing J, Lu J, Li J. Angiotensin II inhibits GABAergic synaptic transmission in dorsolateral periaqueductal gray neurons. Neurosci Lett. 2009;455(1):8-13.

Sarro GD, Paola ED, Gratteri S, Gareri P, Rispoli V, Siniscalchi A, et al. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Pharmacol Res. 2012;65(3):285-96.

Tsuda K. Renin-angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension. International Journal of Hypertension. 2012;2012:1-11.

Pereira MG. Inhibition of the renin-angiotensin system prevents seizures in a rat model of epilepsy. Clin Sci (Lond). 2010;119(11):477-82.

Latchford KJ. Electrophysiological effects of angiotensin II on hypothalamic para ventricular nucleus neurons of the rat; 2008. Available at

Rao RS, Prakash A, Medhi B. Role of different cytokines and seizure susceptibility. A new dimension towards epilepsy research. Indian journal of experimental biology. 2009;47:625-34.